{"recordsFiltered":48486,"recordsTotal":48486,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=34800","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=34200","results":[{"registry_id":"NCT06948760","publication_url":"https://clinicaltrials.gov/study/NCT06948760","title":"Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D [Launchpad Lyumjev]","has_exemption":false,"start_date":"2025-07-23","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"Mark D. DeBoer, MD, MSc., MCR","sponsor_slug":"mark-d-deboer-md-msc-mcr","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03621553","publication_url":"https://clinicaltrials.gov/study/NCT03621553","title":"Vitamin D Homeostasis in Sarcoidosis","has_exemption":false,"start_date":"2010-07-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02560805","publication_url":"https://clinicaltrials.gov/study/NCT02560805","title":"Post-Traumatic Stress Disorder and Cardiovascular Disease Risk: Role of Sympathetic Overactivity and Angiotensin II","has_exemption":false,"start_date":"2015-10-31","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02735707","publication_url":"https://clinicaltrials.gov/study/NCT02735707","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","has_exemption":false,"start_date":"2016-04-11","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"UMC Utrecht","sponsor_slug":"umc-utrecht","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02481245","publication_url":"https://clinicaltrials.gov/study/NCT02481245","title":"A Pan-PPAR Agonist Treatment for Bipolar Depression: A Proof of Concept Study","has_exemption":false,"start_date":"2018-01-11","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04814355","publication_url":"https://clinicaltrials.gov/study/NCT04814355","title":"The Effect of Celecoxib on Neuroinflammation in MDD: PET Imaging of a Novel Treatment Target With [18F]FEPPA","has_exemption":false,"start_date":"2018-08-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Stony Brook University","sponsor_slug":"stony-brook-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03527472","publication_url":"https://clinicaltrials.gov/study/NCT03527472","title":"A Randomized Placebo-controlled, Double Blind Phase 2 Clinical Trial of Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2018-08-23","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03588754","publication_url":"https://clinicaltrials.gov/study/NCT03588754","title":"Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?","has_exemption":false,"start_date":"2018-09-15","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03629340","publication_url":"https://clinicaltrials.gov/study/NCT03629340","title":"Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction","has_exemption":false,"start_date":"2019-02-26","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03796559","publication_url":"https://clinicaltrials.gov/study/NCT03796559","title":"A Prospective Open Label Study of the Use of Magseed® Markers and Sentimag® to Localize Axillary Lymph Nodes with Biopsy-proven Metastases in Breast Cancer Patients","has_exemption":false,"start_date":"2019-06-13","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Endomagnetics Ltd.","sponsor_slug":"endomagnetics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03743649","publication_url":"https://clinicaltrials.gov/study/NCT03743649","title":"Strategies for Persistent Agitated Delirium in Palliative Care","has_exemption":false,"start_date":"2019-07-17","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03879629","publication_url":"https://clinicaltrials.gov/study/NCT03879629","title":"TrAstuzumab Cardiomyopathy Therapeutic Intervention With Carvedilol (TACTIC) Trial","has_exemption":false,"start_date":"2019-08-21","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03707262","publication_url":"https://clinicaltrials.gov/study/NCT03707262","title":"Donor Chimerism and Graft Survival Following Combined HLA-Identical Sibling Living Donor Kidney and Hematopoietic Stem Cell Transplantation Utilizing a Conditioning Regimen of Total Lymphoid Irradiation and Rabbit Anti-Thymocyte Globulin","has_exemption":false,"start_date":"2019-11-06","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Jeffrey Veale, MD","sponsor_slug":"jeffrey-veale-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04517565","publication_url":"https://clinicaltrials.gov/study/NCT04517565","title":"Longitudinal Neuroimaging in Sturge-Weber Syndrome","has_exemption":false,"start_date":"2020-03-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Wayne State University","sponsor_slug":"wayne-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04137107","publication_url":"https://clinicaltrials.gov/study/NCT04137107","title":"Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study","has_exemption":false,"start_date":"2020-06-17","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04432623","publication_url":"https://clinicaltrials.gov/study/NCT04432623","title":"A Phase 1b Sequential Open Label Dose-Ranging Study of Safety, Pharmacokinetics, and Preliminary Activity of Benserazide in Subjects With Beta Thalassemia Intermedia and Sickle Cell Disease","has_exemption":false,"start_date":"2020-10-05","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Phoenicia BioScience","sponsor_slug":"phoenicia-bioscience","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04103879","publication_url":"https://clinicaltrials.gov/study/NCT04103879","title":"A Phase II Open-Label Study of UM171-Expanded Cord Blood Transplantation in Patients With High and Very High Risk Acute Leukemia/Myelodysplasia","has_exemption":false,"start_date":"2020-11-13","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"ExCellThera inc.","sponsor_slug":"excellthera-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04788823","publication_url":"https://clinicaltrials.gov/study/NCT04788823","title":"The Impact of Prednisone on Semen Parameters and Pregnancy Rates Post Vasectomy Reversal: A Randomized, Controlled Trial","has_exemption":false,"start_date":"2021-02-24","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Charitable Union for the Research and Education of Peyronie's Disease","sponsor_slug":"charitable-union-for-the-research-and-education-of-peyronies-disease","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04520776","publication_url":"https://clinicaltrials.gov/study/NCT04520776","title":"A Multicenter, Prospective, Randomized, Clinical Trial Comparing the Safety and Effectiveness of the BAGUERA C Cervical Disc Prosthesis to the Mobi-C® Cervical Disc for the Treatment of Patients With Symptomatic Cervical Disc Disease at a Single Level","has_exemption":false,"start_date":"2021-03-02","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Spineart USA","sponsor_slug":"spineart-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04713475","publication_url":"https://clinicaltrials.gov/study/NCT04713475","title":"Phase 1/2 Open-Label, Multicenter Study to Assess the Safety, Tolerability and Efficacy of a Single Dose of PBGM01 Delivered Into the Cisterna Magna of Pediatric Type 1 (Early Onset) and Type 2a (Late Onset) Infantile GM1 Gangliosidosis","has_exemption":false,"start_date":"2021-03-17","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Gemma Biotherapeutics","sponsor_slug":"gemma-biotherapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04630652","publication_url":"https://clinicaltrials.gov/study/NCT04630652","title":"Immune Modification of Psoriasis by Selective IL-23 Blockade Using Risankizumab","has_exemption":false,"start_date":"2021-04-07","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Jaehwan Kim","sponsor_slug":"jaehwan-kim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04927780","publication_url":"https://clinicaltrials.gov/study/NCT04927780","title":"Perioperative Versus Adjuvant FOLFIRINOX for Resectable Pancreatic Cancer: the PREOPANC-3 Study","has_exemption":false,"start_date":"2021-09-07","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Erasmus Medical Center","sponsor_slug":"erasmus-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05038709","publication_url":"https://clinicaltrials.gov/study/NCT05038709","title":"Does the Addition of a Traction Pad Reduce the Rate of Postoperative Pudendal Neuralgia?","has_exemption":false,"start_date":"2021-10-12","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05263050","publication_url":"https://clinicaltrials.gov/study/NCT05263050","title":"GU-187: Phase II Trial of Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors","has_exemption":false,"start_date":"2022-01-21","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05159765","publication_url":"https://clinicaltrials.gov/study/NCT05159765","title":"Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial","has_exemption":false,"start_date":"2022-01-22","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Visioneering Technologies, Inc","sponsor_slug":"visioneering-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05132439","publication_url":"https://clinicaltrials.gov/study/NCT05132439","title":"Metformin BenefIts Lower Extremities With Intermittent Claudication (MOBILE_IC)","has_exemption":false,"start_date":"2022-03-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04711824","publication_url":"https://clinicaltrials.gov/study/NCT04711824","title":"Phase I/II Study of Stereotactic Radiosurgery With Concurrent Administration of DNA Damage Response (DDR) Inhibitor (OLAparib) Followed by Adjuvant Combination of DuRvalumab (MEDI4736) and Physician's Choice Systemic Therapy in Subjects With BreAst Cancer Brain Metastases","has_exemption":false,"start_date":"2022-03-09","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Colette Shen","sponsor_slug":"colette-shen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05206942","publication_url":"https://clinicaltrials.gov/study/NCT05206942","title":"Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy","has_exemption":false,"start_date":"2022-03-21","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04983030","publication_url":"https://clinicaltrials.gov/study/NCT04983030","title":"A Safety, Immunogenicity and Efficacy Phase 1/2a Study of a Heterologous Ad26.Mos4.HIV, MVA-BN-HIV Vaccine Regimen Plus Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults on Suppressive ART","has_exemption":false,"start_date":"2022-04-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Boris Juelg, MD PhD","sponsor_slug":"boris-juelg-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04403139","publication_url":"https://clinicaltrials.gov/study/NCT04403139","title":"VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination","has_exemption":false,"start_date":"2022-04-27","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05132075","publication_url":"https://clinicaltrials.gov/study/NCT05132075","title":"A Randomized, Controlled, Open Label, Phase III Study Evaluating the Efficacy and Safety of JDQ443 Versus Docetaxel in Previously Treated Subjects With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2022-06-15","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05325645","publication_url":"https://clinicaltrials.gov/study/NCT05325645","title":"A Multicenter, Placebo-controlled, Randomized, Double-blind, Parallel-group Comparison Trial to Investigate the Efficacy and Safety of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia","has_exemption":false,"start_date":"2022-07-21","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Co., Ltd.","sponsor_slug":"otsuka-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05574361","publication_url":"https://clinicaltrials.gov/study/NCT05574361","title":"A Prospective Multi-Center Continued Access Protocol for the Use of the LifePort® Liver Transporter (LLT) System With Vasosol® in Orthotopic Liver Transplants (PILOT™_CA: Perfusion to Improve Liver Outcomes in Transplantation_ Continued Access Arm)","has_exemption":false,"start_date":"2022-09-19","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Organ Recovery Systems, Inc.","sponsor_slug":"organ-recovery-systems-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04922723","publication_url":"https://clinicaltrials.gov/study/NCT04922723","title":"A Study of Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma (PRIDE).","has_exemption":false,"start_date":"2022-10-03","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07024342","publication_url":"https://clinicaltrials.gov/study/NCT07024342","title":"Optimizing Prosthetic Prescription to Mitigate the Effects of Perspiration","has_exemption":false,"start_date":"2022-10-04","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"VA Puget Sound Health Care System","sponsor_slug":"va-puget-sound-health-care-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05461157","publication_url":"https://clinicaltrials.gov/study/NCT05461157","title":"The Application of Preoperative Silicone Ointment and Its Effect on Wound Healing","has_exemption":false,"start_date":"2022-11-14","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05468489","publication_url":"https://clinicaltrials.gov/study/NCT05468489","title":"A Randomized, Open-label Study of Serplulimab Plus Chemotherapy (Carboplatin-Etoposide) in Comparison With Atezolizumab Plus Chemotherapy in Previously Untreated US Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) (ASTRIDE)","has_exemption":false,"start_date":"2022-11-18","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Shanghai Henlius Biotech","sponsor_slug":"shanghai-henlius-biotech","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05470205","publication_url":"https://clinicaltrials.gov/study/NCT05470205","title":"Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension","has_exemption":false,"start_date":"2022-11-28","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05525247","publication_url":"https://clinicaltrials.gov/study/NCT05525247","title":"A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination With Various Anticancer Therapies in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2022-12-21","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Selecxine","sponsor_slug":"selecxine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05693142","publication_url":"https://clinicaltrials.gov/study/NCT05693142","title":"A Phase 1/2/3 Open-label Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacodynamics, and Pharmacokinetics of Intravenous RGX-202 Gene Therapy in Males With Duchenne Muscular Dystrophy (DMD)","has_exemption":false,"start_date":"2023-01-04","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Regenxbio Inc.","sponsor_slug":"regenxbio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05711940","publication_url":"https://clinicaltrials.gov/study/NCT05711940","title":"A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression","has_exemption":false,"start_date":"2023-02-14","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"COMPASS Pathways","sponsor_slug":"compass-pathways","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05547165","publication_url":"https://clinicaltrials.gov/study/NCT05547165","title":"Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants","has_exemption":false,"start_date":"2023-02-21","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05805449","publication_url":"https://clinicaltrials.gov/study/NCT05805449","title":"The BIO RAMP Trial - BIOlogic Augmented Repair of Complex Anal Fistula Using Acellular Matrix and/or Autologous Platelet-rich Plasma","has_exemption":false,"start_date":"2023-02-21","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05652218","publication_url":"https://clinicaltrials.gov/study/NCT05652218","title":"REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT), a Phase I Prospective Randomized Controlled Trial","has_exemption":false,"start_date":"2023-02-26","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Inova Health Care Services","sponsor_slug":"inova-health-care-services","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05768919","publication_url":"https://clinicaltrials.gov/study/NCT05768919","title":"Phase I/II Study of the Tolerability, Safety, and Efficacy of Liposomal Curcumin in Combination With Radiation and Temozolomide in Patients With Newly Diagnosed High-Grade Gliomas","has_exemption":false,"start_date":"2023-03-03","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"SignPath Pharma, Inc.","sponsor_slug":"signpath-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05136820","publication_url":"https://clinicaltrials.gov/study/NCT05136820","title":"Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study","has_exemption":false,"start_date":"2023-03-09","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Occlutech International AB","sponsor_slug":"occlutech-international-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05201404","publication_url":"https://clinicaltrials.gov/study/NCT05201404","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis","has_exemption":false,"start_date":"2023-03-15","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Can-Fite BioPharma","sponsor_slug":"can-fite-biopharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05736653","publication_url":"https://clinicaltrials.gov/study/NCT05736653","title":"Strengthening Task Specific Activation of Paretic Hand Muscles After moderate-to- Severe Chronic Stroke","has_exemption":false,"start_date":"2023-03-29","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05753215","publication_url":"https://clinicaltrials.gov/study/NCT05753215","title":"Omadacycline Versus Standard-of-Care Oral Antibiotic Treatment for Bone and Joint Infections: An Open-Label, Non- Inferiority, Randomized, Controlled Trial","has_exemption":false,"start_date":"2023-05-09","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","sponsor_slug":"lundquist-institute-for-biomedical-innovation-at-harbor-ucla-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05848258","publication_url":"https://clinicaltrials.gov/study/NCT05848258","title":"An Adaptive Phase 2a/2b, Randomized, Double-Blind, Placebo-Controlled Study of LY3871801 in Adult Participants With Moderately-to-Severely Active Rheumatoid Arthritis","has_exemption":false,"start_date":"2023-05-23","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05141149","publication_url":"https://clinicaltrials.gov/study/NCT05141149","title":"A First in Human, Phase 1/2a, Multicentre, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of PBP1510 in Patients With Advanced/Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2023-06-05","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Prestige Biopharma Limited","sponsor_slug":"prestige-biopharma-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05350371","publication_url":"https://clinicaltrials.gov/study/NCT05350371","title":"Evaluation of Pirfenidone as a Therapy in Patients With Predicted Moderate to Severe Acute Pancreatitis","has_exemption":false,"start_date":"2023-08-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05951049","publication_url":"https://clinicaltrials.gov/study/NCT05951049","title":"A Phase 2, Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of AT-02","has_exemption":false,"start_date":"2023-09-21","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Attralus, Inc.","sponsor_slug":"attralus-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06138782","publication_url":"https://clinicaltrials.gov/study/NCT06138782","title":"Identifying Networks Underlying Compulsivity in Anorexia Nervosa for Targeting With Neuromodulation","has_exemption":false,"start_date":"2023-10-16","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06003036","publication_url":"https://clinicaltrials.gov/study/NCT06003036","title":"Accelerated Neuromodulation of Prefrontal Circuitry During Clozapine Treatment","has_exemption":false,"start_date":"2023-12-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Deepak K. Sarpal, M.D.","sponsor_slug":"deepak-k-sarpal-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05094037","publication_url":"https://clinicaltrials.gov/study/NCT05094037","title":"Orthotic Treatment of Diabetic Foot Ulcers: Patient Adherence to Prescribed Wear and Effectiveness of Treatment","has_exemption":false,"start_date":"2023-12-04","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06009926","publication_url":"https://clinicaltrials.gov/study/NCT06009926","title":"Phase II Randomized, Double-Blind, Placebo-Controlled Trial of Broccoli Seed and Sprout Extract (BSSE) to Evaluate Detoxification of Carcinogens in Firefighters","has_exemption":false,"start_date":"2023-12-04","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05644262","publication_url":"https://clinicaltrials.gov/study/NCT05644262","title":"Life's End Benefits of cannaBidiol and tetrahYdrocannabinol (LiBBY)","has_exemption":false,"start_date":"2023-12-18","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05976789","publication_url":"https://clinicaltrials.gov/study/NCT05976789","title":"A Feasibility Study of a Novel, Fully Remote Counseling and Sound Therapy Program for Hyperacusis","has_exemption":false,"start_date":"2023-12-18","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Augustana College","sponsor_slug":"augustana-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05994937","publication_url":"https://clinicaltrials.gov/study/NCT05994937","title":"Glycemic and Cardiometabolic Biomarker Improvements Associated With Reduction in Air Pollution Exposure","has_exemption":false,"start_date":"2023-12-26","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05861453","publication_url":"https://clinicaltrials.gov/study/NCT05861453","title":"An Open-label Mechanistic Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Orally Administered Epeleuton in Patients With Sickle Cell Disease","has_exemption":false,"start_date":"2024-01-10","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Afimmune","sponsor_slug":"afimmune","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06265428","publication_url":"https://clinicaltrials.gov/study/NCT06265428","title":"A Phase III, Multicenter, Open-label, Randomized Study to Compare DB-1303 Versus T-DM1 in Patients With HER2-positive Unresectable/Metastatic Breast Cancer Who Have Been Treated With Trastuzumab and a Taxane (Dynasty-Breast01)","has_exemption":false,"start_date":"2024-01-29","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"DualityBio Inc.","sponsor_slug":"dualitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07288021","publication_url":"https://clinicaltrials.gov/study/NCT07288021","title":"Topical Anesthesia During Catheter Insertion for Cervical Ripening (TOLERANCE)","has_exemption":false,"start_date":"2024-02-05","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Bnai Zion Medical Center","sponsor_slug":"bnai-zion-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05975983","publication_url":"https://clinicaltrials.gov/study/NCT05975983","title":"A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)","has_exemption":false,"start_date":"2024-02-08","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"InSilico Medicine Hong Kong Limited","sponsor_slug":"insilico-medicine-hong-kong-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05424003","publication_url":"https://clinicaltrials.gov/study/NCT05424003","title":"A Randomized Double Blinded Placebo-Controlled Trial of Semaglutide to Prevent Weight Gain Following Liver Transplantation","has_exemption":false,"start_date":"2024-02-22","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06217328","publication_url":"https://clinicaltrials.gov/study/NCT06217328","title":"A Prospective Randomized Control Trial to Compare the Efficacy of the Revi System Therapy on Versus Off in Relieving Urinary Urge Incontinence Episodes.","has_exemption":false,"start_date":"2024-02-24","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"BlueWind Medical","sponsor_slug":"bluewind-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06258486","publication_url":"https://clinicaltrials.gov/study/NCT06258486","title":"Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks","has_exemption":false,"start_date":"2024-02-29","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Kaiser Permanente","sponsor_slug":"kaiser-permanente","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04880707","publication_url":"https://clinicaltrials.gov/study/NCT04880707","title":"Myogenous Face Pain Following Third Molar Extractions Under Intravenous Sedation","has_exemption":false,"start_date":"2024-03-11","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06327451","publication_url":"https://clinicaltrials.gov/study/NCT06327451","title":"Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma","has_exemption":false,"start_date":"2024-04-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Tianjin Medical University General Hospital","sponsor_slug":"tianjin-medical-university-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05703971","publication_url":"https://clinicaltrials.gov/study/NCT05703971","title":"A Phase 1/2 Clinical Trial of Quaratusugene Ozeplasmid and Atezolizumab Maintenance Therapy in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)","has_exemption":false,"start_date":"2024-05-09","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Genprex, Inc.","sponsor_slug":"genprex-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05907330","publication_url":"https://clinicaltrials.gov/study/NCT05907330","title":"A Randomized, Double-blind, Placebo-controlled, Multi-center, Phase 2 Study to Evaluate the Efficacy and Safety of CU104 in Patients With Moderate to Severe Ulcerative Colitis","has_exemption":false,"start_date":"2024-06-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Curacle Co., Ltd.","sponsor_slug":"curacle-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06502964","publication_url":"https://clinicaltrials.gov/study/NCT06502964","title":"Double-Blind, Placebo-Controlled Study of ALTO-101 in Patients With Schizophrenia and Cognitive Impairment","has_exemption":false,"start_date":"2024-06-11","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Alto Neuroscience","sponsor_slug":"alto-neuroscience","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05876078","publication_url":"https://clinicaltrials.gov/study/NCT05876078","title":"DORAYA-HF EU: Assessment of the Doraya Catheter for the Treatment of Volume Overload in Acute Heart Failure Patients With Insufficient Response to Diuretics","has_exemption":false,"start_date":"2024-07-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Revamp Medical Ltd.","sponsor_slug":"revamp-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06603051","publication_url":"https://clinicaltrials.gov/study/NCT06603051","title":"The Effect of Pre-Operative Cryoneurolysis on Post-Operative Narcotic Consumption in Patients Undergoing Autograft ACL Reconstruction","has_exemption":false,"start_date":"2024-08-28","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Virtua Health, Inc.","sponsor_slug":"virtua-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06724614","publication_url":"https://clinicaltrials.gov/study/NCT06724614","title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-dose Study to Evaluate the Efficacy and Safety of VDPHL01 in Male Subjects With Androgenetic Alopecia","has_exemption":false,"start_date":"2024-11-06","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Veradermics, Inc.","sponsor_slug":"veradermics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06658574","publication_url":"https://clinicaltrials.gov/study/NCT06658574","title":"Comparative Efficacy of Two Different Oral Dosage Forms of Acetaminophen for Post-operative Analgesia in Bariatric Surgery Patients","has_exemption":false,"start_date":"2024-11-13","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06568471","publication_url":"https://clinicaltrials.gov/study/NCT06568471","title":"A Randomized, Double-blind, Placebo-controlled Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia","has_exemption":false,"start_date":"2024-11-16","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Hasten Biopharmaceutical Co., Ltd.","sponsor_slug":"hasten-biopharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06248216","publication_url":"https://clinicaltrials.gov/study/NCT06248216","title":"Implementation of an At-Home Multimodal Integrative Therapy Via Virtual Reality for Patients With Cancer-Treatment Associated Symptoms","has_exemption":false,"start_date":"2024-12-04","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07245667","publication_url":"https://clinicaltrials.gov/study/NCT07245667","title":"Clinical Study to Assess Tolnaftate 1% With a Novel Vehicle for the Treatment of Tinea Pedis","has_exemption":false,"start_date":"2024-12-30","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Propedix, Inc.","sponsor_slug":"propedix-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06786884","publication_url":"https://clinicaltrials.gov/study/NCT06786884","title":"A Pilot, Randomized Controlled Trial Evaluating the Effectiveness of Paraffin Wax On Burn Patient Function, Range of Motion and Scar","has_exemption":false,"start_date":"2025-01-06","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Medstar Health Research Institute","sponsor_slug":"medstar-health-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06571669","publication_url":"https://clinicaltrials.gov/study/NCT06571669","title":"BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of IBD.","has_exemption":false,"start_date":"2025-01-31","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Boomerang Medical","sponsor_slug":"boomerang-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06792110","publication_url":"https://clinicaltrials.gov/study/NCT06792110","title":"Evaluation of Artificial Intelligence-Integrated Hearing Aids for Individuals with Hearing Loss","has_exemption":false,"start_date":"2025-02-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06839482","publication_url":"https://clinicaltrials.gov/study/NCT06839482","title":"Efficacy of Robotic Rehabilitation for Neuro Recovery of the Upper Limb in Subacute Stroke Survivors: An International Multicenter Randomized Controlled Trial","has_exemption":false,"start_date":"2025-02-06","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"IRCCS San Raffaele Roma","sponsor_slug":"irccs-san-raffaele-roma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06813430","publication_url":"https://clinicaltrials.gov/study/NCT06813430","title":"Enhancing Healing With Non-Contact Low-Frequency Ultrasound in Fingertip Amputation Treatment: A Prospective Comparative Cohort Study","has_exemption":false,"start_date":"2025-02-10","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"St. Luke's Hospital, Pennsylvania","sponsor_slug":"st-lukes-hospital-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06616844","publication_url":"https://clinicaltrials.gov/study/NCT06616844","title":"Evaluating the Efficacy of Porcine Placental Extracellular Matrix Augmented Wound Care Against Standard Wound Care for the Management of Diabetic Foot Ulcers: A Multi-center, Prospective, Observer-blinded, Randomized Controlled Clinical Trial.","has_exemption":false,"start_date":"2025-02-12","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"ConvaTec Inc.","sponsor_slug":"convatec-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06929923","publication_url":"https://clinicaltrials.gov/study/NCT06929923","title":"An Assessment of Clinical Efficacy of Hypothermic Therapy Following Mild Traumatic Brain Injury (mTBI) in the Adolescent Athlete as Compared to an Untreated Active Control Population","has_exemption":false,"start_date":"2025-02-20","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"TecTraum Inc.","sponsor_slug":"tectraum-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06759272","publication_url":"https://clinicaltrials.gov/study/NCT06759272","title":"Pharmacogenomic Markers of Clopidogrel Resistance in Malaysian CAD Patients: Clinical Efficacy and Economic Evaluation of CYP2C19 Genotype-Guided Therapy","has_exemption":false,"start_date":"2025-02-28","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Nur Hafizah Annezah binti Utuh","sponsor_slug":"nur-hafizah-annezah-binti-utuh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06765824","publication_url":"https://clinicaltrials.gov/study/NCT06765824","title":"Transcranial Magnetic Stimulation in the Treatment of Dual Disorders: Study in Patients with Depression and Tobacco Addiction","has_exemption":false,"start_date":"2025-02-28","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Cardenal Herrera University","sponsor_slug":"cardenal-herrera-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06299891","publication_url":"https://clinicaltrials.gov/study/NCT06299891","title":"Phentermine/Topiramate in Children, Adolescents, and Young Adults With Hypothalamic Obesity: a Pilot and Feasibility Study","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Seattle Children's Hospital","sponsor_slug":"seattle-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06842771","publication_url":"https://clinicaltrials.gov/study/NCT06842771","title":"Pain with Differing Intraperitoneal Washes At the End of Laparoscopic Gynecologic Surgery","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Tennessee","sponsor_slug":"university-of-tennessee","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06936670","publication_url":"https://clinicaltrials.gov/study/NCT06936670","title":"Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes","has_exemption":false,"start_date":"2025-04-30","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Seattle Children's Hospital","sponsor_slug":"seattle-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06721871","publication_url":"https://clinicaltrials.gov/study/NCT06721871","title":"Evaluation of Safety, Tolerability and Efficacy of Crofelemer Following Multiple Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Participants With Microvillus Inclusion Disease (MVID)","has_exemption":false,"start_date":"2025-05-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Napo Pharmaceuticals, Inc.","sponsor_slug":"napo-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07046975","publication_url":"https://clinicaltrials.gov/study/NCT07046975","title":"Bioavailability and Bioequivalence (BA/BE) Study of Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Human Subjects","has_exemption":false,"start_date":"2025-06-15","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Sarfez Pharmaceuticals, Inc.","sponsor_slug":"sarfez-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06990399","publication_url":"https://clinicaltrials.gov/study/NCT06990399","title":"A Randomized, Double-masked, Sham-controlled, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal Tabirafusp Alfa (KSI-101) in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK","has_exemption":false,"start_date":"2025-07-30","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Kodiak Sciences Inc","sponsor_slug":"kodiak-sciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07268586","publication_url":"https://clinicaltrials.gov/study/NCT07268586","title":"Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention","has_exemption":false,"start_date":"2025-08-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Ain Shams University","sponsor_slug":"ain-shams-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06977633","publication_url":"https://clinicaltrials.gov/study/NCT06977633","title":"A pH-Responsive Hydrogel Microneedle Patch for Continuous Measurement of Ketone Bodies and Glucose: CGM-CKM","has_exemption":false,"start_date":"2025-08-30","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Mahla Poudineh","sponsor_slug":"mahla-poudineh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06671015","publication_url":"https://clinicaltrials.gov/study/NCT06671015","title":"A Prospective Randomized Controlled Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure","has_exemption":false,"start_date":"2025-10-04","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220408","publication_url":"https://clinicaltrials.gov/study/NCT07220408","title":"A Single Center, Randomized, Double-masked, Vehicle Controlled Phase 2 Study Evaluating the Safety and Efficacy of TL-925 Ophthalmic Emulsion 0.1% Compared to Vehicle for the Treatment of Seasonal Allergic Conjunctivitis in the Conjunctival Allergen Challenge (Ora-CAC®) Model","has_exemption":false,"start_date":"2025-10-23","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Telios Pharma, Inc.","sponsor_slug":"telios-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07161622","publication_url":"https://clinicaltrials.gov/study/NCT07161622","title":"Effects of Low Level Laser Therapy Versus Muscle Energy Techniques Among Diabetic Patients With Frozen Shoulder","has_exemption":false,"start_date":"2025-10-31","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Lahore","sponsor_slug":"university-of-lahore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07325162","publication_url":"https://clinicaltrials.gov/study/NCT07325162","title":"Development of a Next-Generation Optical Biometer for Eyes With Cataract","has_exemption":false,"start_date":"2025-11-07","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Cassini Technologies","sponsor_slug":"cassini-technologies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06723743","publication_url":"https://clinicaltrials.gov/study/NCT06723743","title":"Transcutaneous Auricular Vagus Nerve Stimulation Effects on Attention and Working Memory: A Pilot Study","has_exemption":false,"start_date":"2025-11-30","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07321834","publication_url":"https://clinicaltrials.gov/study/NCT07321834","title":"A Phase 2, Randomized, Double-blind, Vehicle-Controlled, Multi-Center Clinical Trial Study to Evaluate Ready to Use Injectable AI-09 In Participants With Glabellar Lines","has_exemption":false,"start_date":"2025-12-03","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Eirion Therapeutics Inc.","sponsor_slug":"eirion-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07096856","publication_url":"https://clinicaltrials.gov/study/NCT07096856","title":"Post Market Clinical Study to Evaluate the Performance of the Versius Surgical System","has_exemption":false,"start_date":"2025-12-31","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"CMR Surgical Ltd","sponsor_slug":"cmr-surgical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07311733","publication_url":"https://clinicaltrials.gov/study/NCT07311733","title":"Milky Way Sensor: Device Validation for Infiltrated Tissues","has_exemption":false,"start_date":"2026-01-31","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"ivWatch, LLC","sponsor_slug":"ivwatch-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03428828","publication_url":"https://clinicaltrials.gov/study/NCT03428828","title":"Amygdala rtfMRI Neurofeedback for Treatment Resistant Depression","has_exemption":false,"start_date":"2018-10-22","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Kymberly Young","sponsor_slug":"kymberly-young","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03284385","publication_url":"https://clinicaltrials.gov/study/NCT03284385","title":"A Phase 2 Study of AZD1775 in SETD2-Deficient Advanced Solid Tumor Malignancies","has_exemption":false,"start_date":"2019-01-29","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04069312","publication_url":"https://clinicaltrials.gov/study/NCT04069312","title":"Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)","has_exemption":false,"start_date":"2020-02-11","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04332471","publication_url":"https://clinicaltrials.gov/study/NCT04332471","title":"Treatment of Plantar Fasciitis With Radial Shockwave Therapy vs. Focused Shockwave Therapy: a Randomized Controlled Trial","has_exemption":false,"start_date":"2020-06-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04224493","publication_url":"https://clinicaltrials.gov/study/NCT04224493","title":"Symphony-1: A Phase 1b/3 Double-Blind, Randomized, Active-Controlled, 3-Stage, Biomarker Adaptive Study Of Tazemetostat Or Placebo In Combination With Lenalidomide Plus Rituximab In Subjects With Relapsed/Refractory Follicular Lymphoma","has_exemption":false,"start_date":"2020-06-11","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Epizyme, Inc.","sponsor_slug":"epizyme-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04111172","publication_url":"https://clinicaltrials.gov/study/NCT04111172","title":"A Phase 2A, Dose-Finding Study of Ad5.F35-hGCC-PADRE Vaccine in Adults With Gastrointestinal Adenocarcinomas at Risk of Relapse Post Definitive Surgery and Standard Therapy","has_exemption":false,"start_date":"2020-11-10","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04452955","publication_url":"https://clinicaltrials.gov/study/NCT04452955","title":"An Open Label, Multicenter, Safety and Efficacy Phase 2 Study of PRL3-Zumab in Solid Tumors","has_exemption":false,"start_date":"2020-12-12","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Intra-IMMUSG Pte Ltd","sponsor_slug":"intra-immusg-pte-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04479072","publication_url":"https://clinicaltrials.gov/study/NCT04479072","title":"Aspirin to Prevent Cardiac Dysfunction in Preeclampsia","has_exemption":false,"start_date":"2021-02-15","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05300685","publication_url":"https://clinicaltrials.gov/study/NCT05300685","title":"Peri-operative Oral Pain Control Following Buccal Graft Urethroplasty: Randomized Control Trial of Harvest Site Anesthetic","has_exemption":false,"start_date":"2022-02-15","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05145400","publication_url":"https://clinicaltrials.gov/study/NCT05145400","title":"Phase 2 Study of Isatuximab Plus Lenalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Newly Diagnosed Multiple Myeloma","has_exemption":false,"start_date":"2022-02-18","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03568292","publication_url":"https://clinicaltrials.gov/study/NCT03568292","title":"Effects of Virtual Reality on Pain and Anxiety in Cancer Patients Undergoing Painful Procedures","has_exemption":false,"start_date":"2022-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04260256","publication_url":"https://clinicaltrials.gov/study/NCT04260256","title":"A Pilot Study of Using [18F]F AraG PET Imaging to Evaluate the Immunological Response to Checkpoint Inhibitor Therapy (CkIT) in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2022-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"CellSight Technologies, Inc.","sponsor_slug":"cellsight-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05207709","publication_url":"https://clinicaltrials.gov/study/NCT05207709","title":"A Phase III, Multicenter, Open-label Study of Ribociclib vs. Palbociclib in Patients With Advanced Hormone Receptor-positive/HER2-negative/HER2-Enriched Breast Cancer - HARMONIA Trial","has_exemption":false,"start_date":"2022-03-28","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"SOLTI Breast Cancer Research Group","sponsor_slug":"solti-breast-cancer-research-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05446467","publication_url":"https://clinicaltrials.gov/study/NCT05446467","title":"Safety and Efficacy of Pembrolizumab in Combination With Low-dose PF (Cisplatin and 5-Fluorouracil) as Neoadjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma: a Multi-center, Single-arm Clinical Study Trial","has_exemption":false,"start_date":"2022-09-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Zhejiang Provincial People's Hospital","sponsor_slug":"zhejiang-provincial-peoples-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05629494","publication_url":"https://clinicaltrials.gov/study/NCT05629494","title":"Effect of Non-steroidal Anti-inflammatory Drugs on Serum Prostate Specific Antigen Level","has_exemption":false,"start_date":"2022-09-27","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Albany Medical College","sponsor_slug":"albany-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05306301","publication_url":"https://clinicaltrials.gov/study/NCT05306301","title":"Combination of Ponatinib Plus Chemotherapy As Frontline Treatment For Patients With BCR/ABL1-Like Acute Lymphoblastic Leukemia (BCR/ABL1-Like ALL)","has_exemption":false,"start_date":"2022-10-05","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Gruppo Italiano Malattie EMatologiche dell'Adulto","sponsor_slug":"gruppo-italiano-malattie-ematologiche-delladulto","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04855630","publication_url":"https://clinicaltrials.gov/study/NCT04855630","title":"Combating Alzheimer's Through Sleep and Exercise (CASE)","has_exemption":false,"start_date":"2023-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06206265","publication_url":"https://clinicaltrials.gov/study/NCT06206265","title":"A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control Design","has_exemption":false,"start_date":"2024-01-17","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"TRYP Therapeutics","sponsor_slug":"tryp-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06278909","publication_url":"https://clinicaltrials.gov/study/NCT06278909","title":"Trigeminal Nerve Stimulation in Treatment-resistant Generalized Anxiety Disorder: a Feasibility Study","has_exemption":false,"start_date":"2024-01-18","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Dr. Rafael Freire","sponsor_slug":"dr-rafael-freire","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06178588","publication_url":"https://clinicaltrials.gov/study/NCT06178588","title":"A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Previously Treated Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma","has_exemption":false,"start_date":"2024-02-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05145816","publication_url":"https://clinicaltrials.gov/study/NCT05145816","title":"A Dose-Finding and Proof-of-Concept Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis","has_exemption":false,"start_date":"2024-02-15","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06258187","publication_url":"https://clinicaltrials.gov/study/NCT06258187","title":"Randomized Control Trial of Colorimetric CO2 Detectors for Ventilation Assessment in the Delivery Room","has_exemption":false,"start_date":"2024-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06379425","publication_url":"https://clinicaltrials.gov/study/NCT06379425","title":"Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries: A Randomized Controlled Trial","has_exemption":false,"start_date":"2024-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06250803","publication_url":"https://clinicaltrials.gov/study/NCT06250803","title":"Early Versus Late Pancreatic Stent Placement for Preventing Post-ERCP Pancreatitis: a Multicentre, Randomised Trial","has_exemption":false,"start_date":"2024-04-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"The First Affiliated Hospital of Anhui Medical University","sponsor_slug":"the-first-affiliated-hospital-of-anhui-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06281678","publication_url":"https://clinicaltrials.gov/study/NCT06281678","title":"A Phase 2, Open-label, Multicenter Study of IBI363 (PD1-IL2m) in Subjects with Advanced Solid Malignancies","has_exemption":false,"start_date":"2024-04-08","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Innovent Biologics (Suzhou) Co. Ltd.","sponsor_slug":"innovent-biologics-suzhou-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06230757","publication_url":"https://clinicaltrials.gov/study/NCT06230757","title":"Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot Trial","has_exemption":false,"start_date":"2024-07-08","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06165510","publication_url":"https://clinicaltrials.gov/study/NCT06165510","title":"Convergent Ablation Plus Left Atrial Appendage Isolation for the Treatment of Persistent Atrial Fibrillation","has_exemption":false,"start_date":"2024-08-02","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Barts & The London NHS Trust","sponsor_slug":"barts-the-london-nhs-trust","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07037264","publication_url":"https://clinicaltrials.gov/study/NCT07037264","title":"A Study of the Efficacy and Safety of Non-ablative Fractional Laser in the Treatment of Thyroidectomy Scars","has_exemption":false,"start_date":"2024-09-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Chinese Medical Association","sponsor_slug":"chinese-medical-association","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06845488","publication_url":"https://clinicaltrials.gov/study/NCT06845488","title":"Application of Virtual Reality Technology to Treatment of Social Anxiety","has_exemption":false,"start_date":"2024-11-07","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05587361","publication_url":"https://clinicaltrials.gov/study/NCT05587361","title":"Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms","has_exemption":false,"start_date":"2024-11-26","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06524830","publication_url":"https://clinicaltrials.gov/study/NCT06524830","title":"A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Assess the Efficacy, Safety, and Tolerability of Repeated Doses of VLS-01 Buccal Film in Participants With Treatment Resistant Depression","has_exemption":false,"start_date":"2024-12-30","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"atai Therapeutics, Inc.","sponsor_slug":"atai-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06761547","publication_url":"https://clinicaltrials.gov/study/NCT06761547","title":"Comparsion of Intravenous Injection of Magnesium Sulfate and Lidocaine Effectiveness on the Prevention of Laryngospasm and Analgesic Requirement in Tonsillectomy","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06789575","publication_url":"https://clinicaltrials.gov/study/NCT06789575","title":"Comparison of Bupivacaine Wound Infiltration Versus Wound Instillation to Minimize Postoperative Pain After Thyroid Surgery","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06789393","publication_url":"https://clinicaltrials.gov/study/NCT06789393","title":"Comparison of the Efficacy of Bupivacaine with and Without Dexmedetomidine As an Adjuvant on Penile Block for Postoperative Pain Relief in Pediatrics Undergoing Hypospadias Repair Surgery","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06820567","publication_url":"https://clinicaltrials.gov/study/NCT06820567","title":"English Title of Research Project: Effects of Dapagliflozin on Inflammatory Markers, Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06861738","publication_url":"https://clinicaltrials.gov/study/NCT06861738","title":"Comaring the Effect of Paracetamol in Tratment of Headach","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06773962","publication_url":"https://clinicaltrials.gov/study/NCT06773962","title":"A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of TB006 in Participants With Parkinson's Disease","has_exemption":false,"start_date":"2025-03-20","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"TrueBinding, Inc.","sponsor_slug":"truebinding-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06942182","publication_url":"https://clinicaltrials.gov/study/NCT06942182","title":"Double Blind Placebo-Controlled Parallel Group Study Of Safety And Efficacy Of Isomyosamine In Treating Sarcopenia After Hip Or Femoral Fracture In Gerontological Population","has_exemption":false,"start_date":"2025-05-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"TNF Pharmaceuticals, Inc.","sponsor_slug":"tnf-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06574880","publication_url":"https://clinicaltrials.gov/study/NCT06574880","title":"STARLiT: STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer: A Phase I/II Trial","has_exemption":false,"start_date":"2025-05-13","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Angela Y. Jia, MD PhD","sponsor_slug":"angela-y-jia-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07093034","publication_url":"https://clinicaltrials.gov/study/NCT07093034","title":"Sustained Auricular Nerve Stimulation for PVC Suppression","has_exemption":false,"start_date":"2025-07-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06922942","publication_url":"https://clinicaltrials.gov/study/NCT06922942","title":"MS-FLOWER: MSCopilot Users' Feedback in Real Life - Outcomes Regarding Integration in Patients' pathWay and Users' ExpeRience","has_exemption":false,"start_date":"2025-08-12","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Ad scientiam","sponsor_slug":"ad-scientiam","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07184775","publication_url":"https://clinicaltrials.gov/study/NCT07184775","title":"Maternal Continuous Glucose Monitoring Surveillance Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06764927","publication_url":"https://clinicaltrials.gov/study/NCT06764927","title":"Fibrinogen in Liver Transplant Subjects","has_exemption":false,"start_date":"2025-10-31","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Ezeldeen Abuelkasem","sponsor_slug":"ezeldeen-abuelkasem","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07135947","publication_url":"https://clinicaltrials.gov/study/NCT07135947","title":"To Evaluate the Clinical Impact of the Point Powered System","has_exemption":false,"start_date":"2025-11-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Point Designs","sponsor_slug":"point-designs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224295","publication_url":"https://clinicaltrials.gov/study/NCT07224295","title":"The Effect of Non Invasive Stellate Ganglion Disrupting on Sleep Disturbances on Postmenopausal Female","has_exemption":false,"start_date":"2025-12-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Kafrelsheikh University","sponsor_slug":"kafrelsheikh-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07182058","publication_url":"https://clinicaltrials.gov/study/NCT07182058","title":"Virtual Remote Assessment of Transcranial Electrical Stimulation for Parkinson's Disease Motor Symptoms","has_exemption":false,"start_date":"2026-01-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"U: The Mind Company","sponsor_slug":"u-the-mind-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07331961","publication_url":"https://clinicaltrials.gov/study/NCT07331961","title":"Assessment of the Feasibility and Clinical Efficacy of Low-Intensity Extracorporeal Shockwave Therapy (Li-ESWT) Using the Dornier System in Patients With Vasculogenic Erectile Dysfunction: A Pilot Study","has_exemption":false,"start_date":"2026-01-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07213986","publication_url":"https://clinicaltrials.gov/study/NCT07213986","title":"Pilot Trial of the Vibrant Capsule for Spinal Cord Injury Neurogenic Bowel Dysfunction","has_exemption":false,"start_date":"2026-01-06","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03226808","publication_url":"https://clinicaltrials.gov/study/NCT03226808","title":"Post Market Clinical Follow-up Study of the Zimmer Vivacit-E Highly Crosslinked Polyethylene Liner Used With the Continuum Acetabular Shell","has_exemption":false,"start_date":"2013-10-01","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Zimmer Biomet","sponsor_slug":"zimmer-biomet","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03724175","publication_url":"https://clinicaltrials.gov/study/NCT03724175","title":"The Role of Secondary Bile Acids in Intestinal Inflammation","has_exemption":false,"start_date":"2019-08-26","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04450628","publication_url":"https://clinicaltrials.gov/study/NCT04450628","title":"Esophagogastric Junction Distensibility During Hiatal Hernia Repair","has_exemption":false,"start_date":"2020-09-28","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04300920","publication_url":"https://clinicaltrials.gov/study/NCT04300920","title":"Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial","has_exemption":false,"start_date":"2020-12-17","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Fernando J Martinez","sponsor_slug":"fernando-j-martinez","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04497168","publication_url":"https://clinicaltrials.gov/study/NCT04497168","title":"Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease","has_exemption":false,"start_date":"2021-04-01","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04620759","publication_url":"https://clinicaltrials.gov/study/NCT04620759","title":"Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder","has_exemption":false,"start_date":"2021-04-14","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04910776","publication_url":"https://clinicaltrials.gov/study/NCT04910776","title":"An Open-label, Multinational, Multicenter, Intravenous Infusion Study of the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Avalglucosidase Alfa in Treatment naïve Pediatric Participants With Infantile-Onset Pompe Disease (IOPD)","has_exemption":false,"start_date":"2021-09-01","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05065424","publication_url":"https://clinicaltrials.gov/study/NCT05065424","title":"Use of Premedication for Less Invasive Surfactant Administration: A Randomized Control Trial","has_exemption":false,"start_date":"2022-04-06","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05597891","publication_url":"https://clinicaltrials.gov/study/NCT05597891","title":"A Safety and Feasibility Single-Arm Study of a Novel Catheter Thrombectomy Device For the Treatment of Pulmonary Embolism (ENGULF)","has_exemption":false,"start_date":"2023-01-12","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Endovascular Engineering","sponsor_slug":"endovascular-engineering","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05751278","publication_url":"https://clinicaltrials.gov/study/NCT05751278","title":"A Randomized Trial of Cryoprobe Versus Forceps for Transbronchial Biopsy","has_exemption":false,"start_date":"2023-02-27","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05805436","publication_url":"https://clinicaltrials.gov/study/NCT05805436","title":"The Use of Preoperative Osmotic Laxatives to Improve Recovery of Bowel Function After Robotic-assisted Urologic Surgery","has_exemption":false,"start_date":"2023-06-01","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Chad R. Tracy","sponsor_slug":"chad-r-tracy","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06198959","publication_url":"https://clinicaltrials.gov/study/NCT06198959","title":"Heat Loss in Humans Covered With Full-Body Blankets Connected to Different Warming Devices","has_exemption":false,"start_date":"2024-02-15","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06585423","publication_url":"https://clinicaltrials.gov/study/NCT06585423","title":"Tolerability of an Anesthesia-free Tonometer Tip","has_exemption":false,"start_date":"2024-10-17","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02723994","publication_url":"https://clinicaltrials.gov/study/NCT02723994","title":"A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2-Rearranged and/or JAK Pathway-Mutant Acute Lymphoblastic Leukemia","has_exemption":false,"start_date":"2016-09-30","completion_date":"2026-03-03","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03561584","publication_url":"https://clinicaltrials.gov/study/NCT03561584","title":"A Randomized, Placebo-controlled Pilot Study of Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis (PSC)","has_exemption":false,"start_date":"2018-07-01","completion_date":"2026-03-03","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05277168","publication_url":"https://clinicaltrials.gov/study/NCT05277168","title":"AN OPEN-LABEL, SINGLE-ARM, MULTI-CENTER PHASE I/IIA CLINICAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS","has_exemption":false,"start_date":"2022-05-30","completion_date":"2026-03-03","has_results":false,"results_due":false,"sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","sponsor_slug":"jiangsu-hengrui-medicine-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05959018","publication_url":"https://clinicaltrials.gov/study/NCT05959018","title":"Efficacy & Health Economics of Antimicrobial-impregnated Central Venous Catheters (CVCs) Compared to Non-impregnated CVCs in Central Line-associated Bloodstream Infection Prevention in a Malaysia University Hospital Adult ICU","has_exemption":false,"start_date":"2024-01-19","completion_date":"2026-03-03","has_results":false,"results_due":false,"sponsor_name":"University of Malaya","sponsor_slug":"university-of-malaya","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06054659","publication_url":"https://clinicaltrials.gov/study/NCT06054659","title":"A Randomized Controlled Open-label Study Comparing the Use of Real-time Continuous Glucose Monitoring (Rt-CGM) to Point of Care Testing (POCT) for Glycemic Monitoring in Patients Post-hospitalization for Diabetic Foot Ulcers.","has_exemption":false,"start_date":"2024-02-20","completion_date":"2026-03-03","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06502366","publication_url":"https://clinicaltrials.gov/study/NCT06502366","title":"A Randomized, Placebo-controlled, Double-blind, Multicenter, 12-Week, 3-Way, Partial-replicate Crossover Pharmacodynamic Study to Assess the Equivalence of Budesonide and Albuterol (BDA) Delivered by MDI HFO Compared With BDA Delivered by MDI HFA in Participants With Asthma","has_exemption":false,"start_date":"2024-07-22","completion_date":"2026-03-03","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06404112","publication_url":"https://clinicaltrials.gov/study/NCT06404112","title":"RECOVER-SLEEP: A Platform Protocol for Evaluation of Interventions for Sleep Disturbances in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)","has_exemption":false,"start_date":"2024-07-31","completion_date":"2026-03-03","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06602453","publication_url":"https://clinicaltrials.gov/study/NCT06602453","title":"A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury and Major Adverse Kidney Events","has_exemption":false,"start_date":"2025-01-17","completion_date":"2026-03-03","has_results":false,"results_due":false,"sponsor_name":"Genentech, Inc.","sponsor_slug":"genentech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03438708","publication_url":"https://clinicaltrials.gov/study/NCT03438708","title":"\"PADRES\" (Prior Axitinib as a Determinant of Outcome of REnal Surgery)","has_exemption":false,"start_date":"2018-03-05","completion_date":"2026-03-04","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05348577","publication_url":"https://clinicaltrials.gov/study/NCT05348577","title":"A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Docetaxel Versus Placebo + Docetaxel as Treatment for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)","has_exemption":false,"start_date":"2022-03-25","completion_date":"2026-03-04","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06221969","publication_url":"https://clinicaltrials.gov/study/NCT06221969","title":"Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) 2.4 mg/2.4 mg s.c. Once Weekly Versus Tirzepatide 15 mg s.c. Once Weekly in Participants With Type 2 Diabetes Inadequately Controlled on Metformin With or Without an SGLT2 Inhibitor","has_exemption":false,"start_date":"2024-01-16","completion_date":"2026-03-04","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06290934","publication_url":"https://clinicaltrials.gov/study/NCT06290934","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study Evaluating the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)","has_exemption":false,"start_date":"2024-03-27","completion_date":"2026-03-04","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03404193","publication_url":"https://clinicaltrials.gov/study/NCT03404193","title":"A Phase II Study of Venetoclax in Combination With 10-Day Decitabine in Newly Diagnosed Elderly or Relapsed/Refractory Acute Myeloid Leukemia and Relapsed High-Risk Myelodysplastic Syndrome and Blastic Plasmacytoid Dendritic Cell Neoplasm","has_exemption":false,"start_date":"2018-01-18","completion_date":"2026-03-05","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06295809","publication_url":"https://clinicaltrials.gov/study/NCT06295809","title":"A Phase 2/3, Adaptive, Randomized, Open-label, Clinical Study to Evaluate Neoadjuvant and Adjuvant Intismeran Autogene (mRNA-4157) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care, and Pembrolizumab Monotherapy in Participants With Resectable Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC) (INTerpath-007)","has_exemption":false,"start_date":"2024-04-18","completion_date":"2026-03-05","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06608238","publication_url":"https://clinicaltrials.gov/study/NCT06608238","title":"A Randomized, Double-blind, Three-arm Phase 2 Study Evaluating Two Dose Levels of Microneedle-mediated Delivery of Doxorubicin Compared With a Device-only Control in Patients With Nodular Basal Cell Carcinoma.","has_exemption":false,"start_date":"2024-09-03","completion_date":"2026-03-05","has_results":false,"results_due":false,"sponsor_name":"SkinJect, Inc.","sponsor_slug":"skinject-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07317648","publication_url":"https://clinicaltrials.gov/study/NCT07317648","title":"ClearSight NextGen System Clinical Development Study","has_exemption":false,"start_date":"2025-10-16","completion_date":"2026-03-05","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03680508","publication_url":"https://clinicaltrials.gov/study/NCT03680508","title":"Phase II Study of TSR-022 (Cobolimab) in Combination With TSR-042 (Dostarlimab) for the Treatment of Advanced Hepatocellular Carcinoma","has_exemption":false,"start_date":"2019-12-19","completion_date":"2026-03-06","has_results":false,"results_due":false,"sponsor_name":"University of Hawaii","sponsor_slug":"university-of-hawaii","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04574167","publication_url":"https://clinicaltrials.gov/study/NCT04574167","title":"Effects of tDCS Paired With Cognitive Training on Brain Networks Associated With Alcohol Use Disorder in Veterans","has_exemption":false,"start_date":"2020-01-01","completion_date":"2026-03-06","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05023655","publication_url":"https://clinicaltrials.gov/study/NCT05023655","title":"A Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation","has_exemption":false,"start_date":"2022-01-06","completion_date":"2026-03-06","has_results":false,"results_due":false,"sponsor_name":"Prisma Health-Upstate","sponsor_slug":"prisma-health-upstate","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06040086","publication_url":"https://clinicaltrials.gov/study/NCT06040086","title":"A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tozorakimab in Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations (MIRANDA)","has_exemption":false,"start_date":"2023-09-22","completion_date":"2026-03-06","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05963997","publication_url":"https://clinicaltrials.gov/study/NCT05963997","title":"A Phase 1b/2 Open-label Study of Samuraciclib in Combination With Elacestrant in Participants With Metastatic or Locally Advanced Hormone Receptor-positive and Human Epidermal Growth Factor Receptor 2-negative Breast Cancer","has_exemption":false,"start_date":"2023-10-09","completion_date":"2026-03-06","has_results":false,"results_due":false,"sponsor_name":"Carrick Therapeutics Limited","sponsor_slug":"carrick-therapeutics-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04100564","publication_url":"https://clinicaltrials.gov/study/NCT04100564","title":"Prehospital Airway Control Trial : A Randomized Controlled Trial of Prehospital Airway Management Strategy for Trauma Patients","has_exemption":false,"start_date":"2021-04-01","completion_date":"2026-03-07","has_results":false,"results_due":false,"sponsor_name":"Jason Sperry","sponsor_slug":"jason-sperry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06829914","publication_url":"https://clinicaltrials.gov/study/NCT06829914","title":"Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes","has_exemption":false,"start_date":"2024-03-07","completion_date":"2026-03-07","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05611242","publication_url":"https://clinicaltrials.gov/study/NCT05611242","title":"Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial","has_exemption":false,"start_date":"2024-05-08","completion_date":"2026-03-08","has_results":false,"results_due":false,"sponsor_name":"Mercy Health, Ohio","sponsor_slug":"mercy-health-ohio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03868293","publication_url":"https://clinicaltrials.gov/study/NCT03868293","title":"Low Intensity Focused Ultrasound Treatment for Epilepsy: A Pilot Trial","has_exemption":false,"start_date":"2019-02-07","completion_date":"2026-03-09","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05725902","publication_url":"https://clinicaltrials.gov/study/NCT05725902","title":"A Pilot Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease","has_exemption":false,"start_date":"2024-03-09","completion_date":"2026-03-09","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06881251","publication_url":"https://clinicaltrials.gov/study/NCT06881251","title":"A Phase 2b, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of JNJ-95475939 for the Treatment of Participants With Moderate to Severe AD","has_exemption":false,"start_date":"2025-02-26","completion_date":"2026-03-09","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03937154","publication_url":"https://clinicaltrials.gov/study/NCT03937154","title":"PROCLAIM: A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy-induced Thrombocytopenia in Patients Receiving Chemotherapy for Treatment of Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer","has_exemption":false,"start_date":"2020-02-26","completion_date":"2026-03-10","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05440643","publication_url":"https://clinicaltrials.gov/study/NCT05440643","title":"A Phase I/II Trial in 3 Parts Assessing the Safety, Tolerability, and Efficacy of a Once-daily Peanut Sublingual Immunotherapy (SLIT) Tablet in Adults, Adolescents, and Children With Peanut Allergy","has_exemption":false,"start_date":"2022-09-07","completion_date":"2026-03-10","has_results":false,"results_due":false,"sponsor_name":"ALK-Abelló A/S","sponsor_slug":"alk-abello-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05109364","publication_url":"https://clinicaltrials.gov/study/NCT05109364","title":"The Effect of alpha1- Adrenergic Receptor Antagonist Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease: A Follow up Study","has_exemption":false,"start_date":"2022-09-23","completion_date":"2026-03-10","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07103720","publication_url":"https://clinicaltrials.gov/study/NCT07103720","title":"The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron","has_exemption":false,"start_date":"2025-11-05","completion_date":"2026-03-10","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03858205","publication_url":"https://clinicaltrials.gov/study/NCT03858205","title":"Phase II Multi-Institutional Study of Low-Dose (2Gy) Palliative Radiotherapy in the Treatment of Symptomatic Bone Metastases From Multiple Myeloma","has_exemption":false,"start_date":"2019-03-11","completion_date":"2026-03-11","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04225156","publication_url":"https://clinicaltrials.gov/study/NCT04225156","title":"A Phase 3, Multicenter, Open-label, Long-term Trial to Evaluate the Safety and Efficacy of Efgartigimod (ARGX 113) 10 mg/kg Intravenous in Adult Patients With Primary Immune Thrombocytopenia.","has_exemption":false,"start_date":"2020-06-02","completion_date":"2026-03-11","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04904302","publication_url":"https://clinicaltrials.gov/study/NCT04904302","title":"A Phase II Trial of Sitravatinib Plus Nivolumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma Who Progressed on Prior Treatment Acronym: SNAPI (Sitravatinib and Nivolumab After Prior Immunotherapy)","has_exemption":false,"start_date":"2022-05-03","completion_date":"2026-03-11","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06492304","publication_url":"https://clinicaltrials.gov/study/NCT06492304","title":"A Phase 1/2 Dose Evaluation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD70 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX131) in Adult Subjects With Relapsed/Refractory Hematologic Malignancies","has_exemption":false,"start_date":"2024-08-13","completion_date":"2026-03-11","has_results":false,"results_due":false,"sponsor_name":"CRISPR Therapeutics","sponsor_slug":"crispr-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06815965","publication_url":"https://clinicaltrials.gov/study/NCT06815965","title":"An Open-Label Phase 2a Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients With Dementia With Lewy Bodies (DLB)","has_exemption":false,"start_date":"2024-10-16","completion_date":"2026-03-11","has_results":false,"results_due":false,"sponsor_name":"EIP Pharma Inc","sponsor_slug":"eip-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06799741","publication_url":"https://clinicaltrials.gov/study/NCT06799741","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Compare the Safety and Efficacy of 3 Dose Levels of AV-1 in Healthy Adults Challenged With a Controlled Human Infection Strain of DENV-3","has_exemption":false,"start_date":"2025-01-07","completion_date":"2026-03-11","has_results":false,"results_due":false,"sponsor_name":"AbViro LLC","sponsor_slug":"abviro-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06869785","publication_url":"https://clinicaltrials.gov/study/NCT06869785","title":"An Open-label, Randomized, Parallel Group, Non-inferiority Study to Investigate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab, Followed by Extended Treatment in Participants With Relapsing Multiple Sclerosis","has_exemption":false,"start_date":"2025-03-13","completion_date":"2026-03-11","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06850363","publication_url":"https://clinicaltrials.gov/study/NCT06850363","title":"ExaStim Upper Limb Home Use Clinical Validation Study","has_exemption":false,"start_date":"2025-03-17","completion_date":"2026-03-11","has_results":false,"results_due":false,"sponsor_name":"Niche Biomedical, Inc. dba ANEUVO","sponsor_slug":"niche-biomedical-inc-dba-aneuvo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03360721","publication_url":"https://clinicaltrials.gov/study/NCT03360721","title":"A Phase 2, Study of Apalutamide and Abiraterone Acetate in Castration-Resistant Metastatic Prostate Cancer Patients Evaluating a Predetermined Biomarker Signature","has_exemption":false,"start_date":"2018-03-06","completion_date":"2026-03-12","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03643510","publication_url":"https://clinicaltrials.gov/study/NCT03643510","title":"Phase II Study of Fulvestrant in Combination With Abemaciclib in Hormone Receptor Positive Adenocarcinoma of Endometrium","has_exemption":false,"start_date":"2018-08-21","completion_date":"2026-03-12","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06036836","publication_url":"https://clinicaltrials.gov/study/NCT06036836","title":"A Multicenter, Randomized, Double-Blind, Phase 2, Basket Study of MK-4280A, a Coformulation of Favezelimab (MK-4280) With Pembrolizumab (MK-3475) in Selected Solid Tumors (KeyForm-010)","has_exemption":false,"start_date":"2023-09-29","completion_date":"2026-03-12","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06012435","publication_url":"https://clinicaltrials.gov/study/NCT06012435","title":"A Randomized, Phase 3, Open-label Study to Evaluate Sigvotatug Vedotin Compared With Docetaxel in Adult Participants With Previously Treated Non-small Cell Lung Cancer (Be6A Lung-01)","has_exemption":false,"start_date":"2024-02-21","completion_date":"2026-03-12","has_results":false,"results_due":false,"sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","sponsor_slug":"seagen-a-wholly-owned-subsidiary-of-pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06425159","publication_url":"https://clinicaltrials.gov/study/NCT06425159","title":"A Phase 2/3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BHV-7000 as Adjunctive Therapy in Subjects With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures, With Open-label Extension","has_exemption":false,"start_date":"2024-06-20","completion_date":"2026-03-12","has_results":false,"results_due":false,"sponsor_name":"Biohaven Therapeutics Ltd.","sponsor_slug":"biohaven-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06685068","publication_url":"https://clinicaltrials.gov/study/NCT06685068","title":"A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2024-11-13","completion_date":"2026-03-12","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06698042","publication_url":"https://clinicaltrials.gov/study/NCT06698042","title":"A Phase 3 Randomized, Open-label Clinical Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Versus Intravenous Pembrolizumab, in the First-line Treatment of Participants With Metastatic Non-small Cell Lung Cancer With PD-L1 TPS 50% or Greater","has_exemption":false,"start_date":"2024-11-21","completion_date":"2026-03-12","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02627508","publication_url":"https://clinicaltrials.gov/study/NCT02627508","title":"Randomized Controlled Pilot Trial of Pregnenolone in Autism","has_exemption":false,"start_date":"2016-01-29","completion_date":"2026-03-13","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05393258","publication_url":"https://clinicaltrials.gov/study/NCT05393258","title":"A Pilot Study of Temporally-modulated Pulsed Radiation Therapy to Reirradiate Recurrent IDH-mutant Gliomas After Prior External Beam Radiation Therapy","has_exemption":false,"start_date":"2022-06-28","completion_date":"2026-03-13","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05815784","publication_url":"https://clinicaltrials.gov/study/NCT05815784","title":"Myopia Control in the Pediatric Population: a Comparison of MiSight, Naturalvue Multifocal, and Atropine 0.05%","has_exemption":false,"start_date":"2023-05-02","completion_date":"2026-03-13","has_results":false,"results_due":false,"sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","sponsor_slug":"ann-robert-h-lurie-childrens-hospital-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06140836","publication_url":"https://clinicaltrials.gov/study/NCT06140836","title":"Randomized, Open-label, Multicenter, Phase 3 Trial of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)","has_exemption":false,"start_date":"2023-12-21","completion_date":"2026-03-13","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06336343","publication_url":"https://clinicaltrials.gov/study/NCT06336343","title":"A Study to Evaluate the Safety and Efficacy of Bimekizumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17 or IL-23 Therapies","has_exemption":false,"start_date":"2024-06-03","completion_date":"2026-03-13","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06159777","publication_url":"https://clinicaltrials.gov/study/NCT06159777","title":"Pre- and Post-operative Compared to Post-operative Only Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery","has_exemption":false,"start_date":"2024-06-05","completion_date":"2026-03-13","has_results":false,"results_due":false,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05649722","publication_url":"https://clinicaltrials.gov/study/NCT05649722","title":"An Open-Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease","has_exemption":false,"start_date":"2023-05-11","completion_date":"2026-03-14","has_results":false,"results_due":false,"sponsor_name":"Insmed Incorporated","sponsor_slug":"insmed-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00585507","publication_url":"https://clinicaltrials.gov/study/NCT00585507","title":"A Phase II Multi-Center Study to Evaluate the Efficacy and Safety of 500mg of Fulvestrant (Faslodex) as a First Line Hormonal Treatment in Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer","has_exemption":false,"start_date":"2004-04-30","completion_date":"2026-03-15","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05721677","publication_url":"https://clinicaltrials.gov/study/NCT05721677","title":"The Impact of Central-line Exit-site Sealing With 2-octyl Cyanoacrylate Adhesive on CLABSI in Pediatric Cardiac Intensive Care Unit","has_exemption":false,"start_date":"2023-03-15","completion_date":"2026-03-15","has_results":false,"results_due":false,"sponsor_name":"Rabin Medical Center","sponsor_slug":"rabin-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06052969","publication_url":"https://clinicaltrials.gov/study/NCT06052969","title":"PERFUSION AIS - Pulse Endovascular ReperFUSION for Acute Ischemic Stroke: An Early Feasibility Clinical Study","has_exemption":false,"start_date":"2023-10-01","completion_date":"2026-03-15","has_results":false,"results_due":false,"sponsor_name":"Euphrates Vascular, Inc.","sponsor_slug":"euphrates-vascular-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06591650","publication_url":"https://clinicaltrials.gov/study/NCT06591650","title":"A Phase II Study of Gemcitabine, Cisplatin, Nab-Paclitaxel, and Durvalumab in Locally Advanced or Metastatic Gallbladder Cancer","has_exemption":false,"start_date":"2024-09-10","completion_date":"2026-03-15","has_results":false,"results_due":false,"sponsor_name":"Fudan University","sponsor_slug":"fudan-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06729255","publication_url":"https://clinicaltrials.gov/study/NCT06729255","title":"A Single Academic Center, Prospective Cohort With Retrospective Loss-of-resistance Comparator, Proof of Concept Study to Evaluate the Safety, Efficacy, and Usability of the EpiZact Device for Parturients Undergoing Epidural Labor Analgesia","has_exemption":false,"start_date":"2025-03-15","completion_date":"2026-03-15","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06919081","publication_url":"https://clinicaltrials.gov/study/NCT06919081","title":"Phase II Study of the Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease","has_exemption":false,"start_date":"2025-08-01","completion_date":"2026-03-15","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07140640","publication_url":"https://clinicaltrials.gov/study/NCT07140640","title":"Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.","has_exemption":false,"start_date":"2025-09-15","completion_date":"2026-03-15","has_results":false,"results_due":false,"sponsor_name":"Aswan University","sponsor_slug":"aswan-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07275424","publication_url":"https://clinicaltrials.gov/study/NCT07275424","title":"Open-Label, Single-Arm Phase 2a Pilot Study to Evaluate the Safety and Tolerability of a Daily Subcutaneous Dose of Elamipretide in Older Adults","has_exemption":false,"start_date":"2025-11-26","completion_date":"2026-03-15","has_results":false,"results_due":false,"sponsor_name":"David Marcinek","sponsor_slug":"david-marcinek","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03997123","publication_url":"https://clinicaltrials.gov/study/NCT03997123","title":"A Phase III Double-blind Randomised Study Assessing the Efficacy and Safety of Capivasertib/+Paclitaxel vs Placebo+Paclitaxel as First-line Treatment for Patients With Locally Advanced (Inoperable) or Metastatic TNBC.","has_exemption":false,"start_date":"2019-06-25","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05352672","publication_url":"https://clinicaltrials.gov/study/NCT05352672","title":"A Phase 3 Trial of Fianlimab (REGN3767, Anti-LAG-3) + Cemiplimab Versus Pembrolizumab in Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma","has_exemption":false,"start_date":"2022-07-14","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05803421","publication_url":"https://clinicaltrials.gov/study/NCT05803421","title":"A Phase 3, Open-Label Study of Once Daily LY3502970 Compared With Insulin Glargine in Adult Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk","has_exemption":false,"start_date":"2023-04-03","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05962606","publication_url":"https://clinicaltrials.gov/study/NCT05962606","title":"An Exploratory, Multi-Centre, Interventional, Prospective, Randomised, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of AON-D21 in Patients With Severe Community-Acquired Pneumonia.","has_exemption":false,"start_date":"2024-02-02","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"Aptarion Biotech AG","sponsor_slug":"aptarion-biotech-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06159790","publication_url":"https://clinicaltrials.gov/study/NCT06159790","title":"A Randomized, Double-blind, Parallel-group Study to Compare Efficacy, Safety, and Immunogenicity of GME751 (Proposed Pembrolizumab Biosimilar) and EU-authorized Keytruda® in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2024-04-29","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"Sandoz","sponsor_slug":"sandoz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06613685","publication_url":"https://clinicaltrials.gov/study/NCT06613685","title":"An Operationally Seamless Phase 2/3, Randomized, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of GS-1720 in Combination With GS-4182 Versus Biktarvy in Treatment-Naive People With HIV-1","has_exemption":false,"start_date":"2024-10-21","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06911424","publication_url":"https://clinicaltrials.gov/study/NCT06911424","title":"A Phase 3 Randomized, Multi-Center, Placebo-Controlled, Masked Study to Evaluate the Clinical Efficacy and Safety of Fusidic Acid 1% Viscous Topical Antibiotic Eye Drops for the Treatment of Suspected Bacterial Conjunctivitis","has_exemption":false,"start_date":"2025-03-21","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"Baxis Pharmaceuticals, Inc.","sponsor_slug":"baxis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287423","publication_url":"https://clinicaltrials.gov/study/NCT07287423","title":"LEadless Advanced Pacing 2 Chronic Early Feasibility Study","has_exemption":false,"start_date":"2025-12-13","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05875168","publication_url":"https://clinicaltrials.gov/study/NCT05875168","title":"Phase 1/2, Open-label, Multicenter, First-in-Human Study of DS-3939a in Subjects With Advanced Solid Tumors","has_exemption":false,"start_date":"2023-08-18","completion_date":"2026-03-17","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06113471","publication_url":"https://clinicaltrials.gov/study/NCT06113471","title":"A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo","has_exemption":false,"start_date":"2023-11-27","completion_date":"2026-03-17","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05513027","publication_url":"https://clinicaltrials.gov/study/NCT05513027","title":"A Prospective Study of the Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection","has_exemption":false,"start_date":"2024-03-06","completion_date":"2026-03-17","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03217188","publication_url":"https://clinicaltrials.gov/study/NCT03217188","title":"A Phase II Study of Proton Re-Irradiation for Recurrent Head and Neck Cancer","has_exemption":false,"start_date":"2017-07-10","completion_date":"2026-03-18","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03961347","publication_url":"https://clinicaltrials.gov/study/NCT03961347","title":"Evaluation of Safety, Tolerability and Immunological Responses to Lactobacillus Johnsonii N6.2 Supplementation in Adults With Diabetes Type 1","has_exemption":false,"start_date":"2020-02-01","completion_date":"2026-03-18","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04901169","publication_url":"https://clinicaltrials.gov/study/NCT04901169","title":"Angiotensin II in Liver Transplantation (AngLT-1): A Pilot Randomized Controlled Trial","has_exemption":false,"start_date":"2022-06-28","completion_date":"2026-03-18","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06423781","publication_url":"https://clinicaltrials.gov/study/NCT06423781","title":"A Phase 2, Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of BHV-7000 in Treatment of Major Depressive Disorder (MDD)","has_exemption":false,"start_date":"2024-08-01","completion_date":"2026-03-18","has_results":false,"results_due":false,"sponsor_name":"Biohaven Therapeutics Ltd.","sponsor_slug":"biohaven-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06404099","publication_url":"https://clinicaltrials.gov/study/NCT06404099","title":"RECOVER-SLEEP: A Platform Protocol for Evaluation of Interventions for Sleep Disturbances in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)","has_exemption":false,"start_date":"2024-08-12","completion_date":"2026-03-18","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02816021","publication_url":"https://clinicaltrials.gov/study/NCT02816021","title":"Phase II Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma","has_exemption":false,"start_date":"2017-02-14","completion_date":"2026-03-19","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03786081","publication_url":"https://clinicaltrials.gov/study/NCT03786081","title":"A Phase 1b/2 Open-Label Trial of Tisotumab Vedotin (HuMax®-TF-ADC) Monotherapy and in Combination With Other Agents in Subjects With Recurrent or Stage IVB Cervical Cancer","has_exemption":false,"start_date":"2019-02-27","completion_date":"2026-03-19","has_results":false,"results_due":false,"sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","sponsor_slug":"seagen-a-wholly-owned-subsidiary-of-pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05304767","publication_url":"https://clinicaltrials.gov/study/NCT05304767","title":"An Open-label Extension Study to Assess the Long-term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia","has_exemption":false,"start_date":"2022-03-07","completion_date":"2026-03-19","has_results":false,"results_due":false,"sponsor_name":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","sponsor_slug":"karuna-therapeutics-inc-a-bristol-myers-squibb-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06312020","publication_url":"https://clinicaltrials.gov/study/NCT06312020","title":"A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of HZN-1116 in Participants With Sjögren's Syndrome","has_exemption":false,"start_date":"2024-05-09","completion_date":"2026-03-19","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06333860","publication_url":"https://clinicaltrials.gov/study/NCT06333860","title":"A Phase 4 Multicenter, Randomized, Open-label, Efficacy Assessor Blinded Study of Risankizumab Compared to Deucravacitinib for the Treatment of Adult Subjects With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy","has_exemption":false,"start_date":"2024-05-10","completion_date":"2026-03-19","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07193563","publication_url":"https://clinicaltrials.gov/study/NCT07193563","title":"The ENCalmSocial Trial: A Randomized, Double-Blind, Placebo-Controlled Monotherapy Trial to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder","has_exemption":false,"start_date":"2025-09-05","completion_date":"2026-03-19","has_results":false,"results_due":false,"sponsor_name":"Engrail Therapeutics INC","sponsor_slug":"engrail-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07168148","publication_url":"https://clinicaltrials.gov/study/NCT07168148","title":"Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants","has_exemption":false,"start_date":"2025-11-10","completion_date":"2026-03-19","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02399371","publication_url":"https://clinicaltrials.gov/study/NCT02399371","title":"A Phase II Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Malignant Mesothelioma","has_exemption":false,"start_date":"2015-03-31","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04817254","publication_url":"https://clinicaltrials.gov/study/NCT04817254","title":"Phase II Trial Evaluating the Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma","has_exemption":false,"start_date":"2021-12-08","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05348447","publication_url":"https://clinicaltrials.gov/study/NCT05348447","title":"Randomized Trial of Intercostal Nerve Cryotherapy in Patients Undergoing Minimally Invasive Pulmonary Resection","has_exemption":false,"start_date":"2022-04-21","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","sponsor_slug":"allegheny-singer-research-institute-also-known-as-allegheny-health-network-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05378399","publication_url":"https://clinicaltrials.gov/study/NCT05378399","title":"SmartSteps: A Context-Aware, Pre-Exposure Prophylaxis Adherence Intervention for Individuals With Substance Use Disorder","has_exemption":false,"start_date":"2022-12-20","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06593600","publication_url":"https://clinicaltrials.gov/study/NCT06593600","title":"A Phase 2 Double-Blind Placebo-Controlled Single-Dose Study of Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of REGN7544, an NPR1 Antagonist Monoclonal Antibody, in Patients With Postural Orthostatic Tachycardia Syndrome","has_exemption":false,"start_date":"2024-11-13","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06716216","publication_url":"https://clinicaltrials.gov/study/NCT06716216","title":"A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of BGM0504 Versus Semaglutide Once Weekly As Add-on Therapy to Metformin And/or Sulfonylureas in Patients with Type 2 Diabetes","has_exemption":false,"start_date":"2024-11-29","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"BrightGene Bio-Medical Technology Co., Ltd.","sponsor_slug":"brightgene-bio-medical-technology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06887933","publication_url":"https://clinicaltrials.gov/study/NCT06887933","title":"A Prospective, Multicentre, Open Labelled, Single Arm Phase-IV Clinical Trial of Niraparib in Indian Patients With Advanced or Relapsed Ovarian Cancer Who Are in Complete or Partial Response Following Platinum Based Chemotherapy","has_exemption":false,"start_date":"2025-04-22","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06831084","publication_url":"https://clinicaltrials.gov/study/NCT06831084","title":"Acute Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer Patients With the Use of Silver-Plated Technology: A Single Arm Phase II Trial","has_exemption":false,"start_date":"2025-05-01","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"Parul Barry","sponsor_slug":"parul-barry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07346261","publication_url":"https://clinicaltrials.gov/study/NCT07346261","title":"Impact of Digital High-Intensity Respiratory Muscle Training on Ventilatory Function and Functional Capacity in Patients With COPD","has_exemption":false,"start_date":"2026-01-20","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"Cairo University","sponsor_slug":"cairo-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06523621","publication_url":"https://clinicaltrials.gov/study/NCT06523621","title":"Nivolumab As An Adjunctive Therapy In Relapsed Refractory Multiple Myeloma Patients With Sub-Optimal Response To Idecabtagene Vicleucel","has_exemption":false,"start_date":"2025-02-28","completion_date":"2026-03-21","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03485209","publication_url":"https://clinicaltrials.gov/study/NCT03485209","title":"Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors","has_exemption":false,"start_date":"2018-06-25","completion_date":"2026-03-23","has_results":false,"results_due":false,"sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","sponsor_slug":"seagen-a-wholly-owned-subsidiary-of-pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04569747","publication_url":"https://clinicaltrials.gov/study/NCT04569747","title":"20-347 NCT Number Title A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer (ADEPT)","has_exemption":false,"start_date":"2021-01-11","completion_date":"2026-03-23","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06625671","publication_url":"https://clinicaltrials.gov/study/NCT06625671","title":"A Randomized, Double-Blind, Phase 1/2a Study to Evaluate the Safety, Tolerability, PK and PD of DB-2304 for Injection in Healthy Adult Participants and Participants With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus","has_exemption":false,"start_date":"2024-10-04","completion_date":"2026-03-23","has_results":false,"results_due":false,"sponsor_name":"DualityBio Inc.","sponsor_slug":"dualitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06303570","publication_url":"https://clinicaltrials.gov/study/NCT06303570","title":"A Single-Blind, Placebo-Control, Randomized Phase 2 Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With Dercum's Disease Lipomas","has_exemption":false,"start_date":"2024-11-27","completion_date":"2026-03-23","has_results":false,"results_due":false,"sponsor_name":"Caliway Biopharmaceuticals Co., Ltd.","sponsor_slug":"caliway-biopharmaceuticals-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06710795","publication_url":"https://clinicaltrials.gov/study/NCT06710795","title":"AFFIX: Evaluation of the performAnce and saFety of the MaxTack™ Motorized FIXation Device in Subjects Undergoing Repair of Ventral Hernia by Minimally Invasive Surgery","has_exemption":false,"start_date":"2025-06-16","completion_date":"2026-03-23","has_results":false,"results_due":false,"sponsor_name":"Medtronic - MITG","sponsor_slug":"medtronic-mitg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07011797","publication_url":"https://clinicaltrials.gov/study/NCT07011797","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of CX11 Tablets in Overweight/Obese Participants","has_exemption":false,"start_date":"2025-06-17","completion_date":"2026-03-23","has_results":false,"results_due":false,"sponsor_name":"Corxel Pharmaceuticals","sponsor_slug":"corxel-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03364114","publication_url":"https://clinicaltrials.gov/study/NCT03364114","title":"Interscope Endorotor® Mucosal Resection System With Continued Ablative Therapy In Subjects With Refractory Dysplastic Barrett's Esophagus","has_exemption":false,"start_date":"2018-02-09","completion_date":"2026-03-24","has_results":false,"results_due":false,"sponsor_name":"Interscope, Inc.","sponsor_slug":"interscope-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03328026","publication_url":"https://clinicaltrials.gov/study/NCT03328026","title":"A Phase I/II Study of the SV-BR-1-GM Regimen in Metastatic or Locally Recurrent Breast Cancer Patients in Combination With Retifanlimab","has_exemption":false,"start_date":"2018-03-16","completion_date":"2026-03-24","has_results":false,"results_due":false,"sponsor_name":"BriaCell Therapeutics Corporation","sponsor_slug":"briacell-therapeutics-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05092347","publication_url":"https://clinicaltrials.gov/study/NCT05092347","title":"A Dose Escalation and Proof-of-Concept Study of Vonsetamig (BCMA × CD3 Bispecific Antibody) for Desensitization of Chronic Kidney Disease Patients in Need of Kidney Transplantation Who Are Highly Sensitized to Human Leukocyte Antigen","has_exemption":false,"start_date":"2022-08-02","completion_date":"2026-03-24","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02625480","publication_url":"https://clinicaltrials.gov/study/NCT02625480","title":"A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-X19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (ZUMA-4)","has_exemption":false,"start_date":"2016-02-01","completion_date":"2026-03-25","has_results":false,"results_due":false,"sponsor_name":"Kite, A Gilead Company","sponsor_slug":"kite-a-gilead-company","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05867602","publication_url":"https://clinicaltrials.gov/study/NCT05867602","title":"Clinical Efficacy of High-dose Albumin Administration Versus Standard Dose in Patients With Advanced Cirrhosis: Open Label Randomized Clinical Trial","has_exemption":false,"start_date":"2019-03-25","completion_date":"2026-03-25","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04926818","publication_url":"https://clinicaltrials.gov/study/NCT04926818","title":"A 2-year Randomized, 3-arm, Double-blind, Non-inferiority Study Comparing the Efficacy and Safety of Ofatumumab and Siponimod Versus Fingolimod in Pediatric Patients With Multiple Sclerosis Followed by an Open-label Extension","has_exemption":false,"start_date":"2021-10-05","completion_date":"2026-03-25","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05180474","publication_url":"https://clinicaltrials.gov/study/NCT05180474","title":"First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of GEN1047 in Subjects With Malignant Solid Tumors","has_exemption":false,"start_date":"2021-12-13","completion_date":"2026-03-25","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06267560","publication_url":"https://clinicaltrials.gov/study/NCT06267560","title":"A Randomized Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Pelacarsen (TQJ230) in US Black/African American & Hispanic Patient Populations With Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease","has_exemption":false,"start_date":"2024-04-24","completion_date":"2026-03-25","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06696170","publication_url":"https://clinicaltrials.gov/study/NCT06696170","title":"Initial Safety and Performance of the CellFX® Nano-PFA 360 Catheter Endocardial Ablation System for the Treatment of Atrial Fibrillation","has_exemption":false,"start_date":"2024-07-25","completion_date":"2026-03-25","has_results":false,"results_due":false,"sponsor_name":"Pulse Biosciences, Inc.","sponsor_slug":"pulse-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07398989","publication_url":"https://clinicaltrials.gov/study/NCT07398989","title":"A Clinical Study to Assess Efficacy and Tolerability of a Topical Skincare Product on Adults With Mature, Crepey Skin","has_exemption":false,"start_date":"2025-08-12","completion_date":"2026-03-25","has_results":false,"results_due":false,"sponsor_name":"Galderma R&D","sponsor_slug":"galderma-rd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05864846","publication_url":"https://clinicaltrials.gov/study/NCT05864846","title":"A Phase 4, Interventional, Multicenter, Open-Label, Single-Arm Study to Assess Behavioral and Other Co-occurring Outcomes Following Treatment With EPID(I/Y)OLEX as Add-on Therapy in Participants (Aged 1 to 65 Years Old) With Seizures Associated With Tuberous Sclerosis Complex","has_exemption":false,"start_date":"2023-06-29","completion_date":"2026-03-26","has_results":false,"results_due":false,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06393907","publication_url":"https://clinicaltrials.gov/study/NCT06393907","title":"A Randomized Trial of Hemostatic Forceps Versus Bipolar Electrocautery Probes for High-Risk Bleeding Gastroduodenal Ulcers","has_exemption":false,"start_date":"2024-03-26","completion_date":"2026-03-26","has_results":false,"results_due":false,"sponsor_name":"Mahidol University","sponsor_slug":"mahidol-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04230148","publication_url":"https://clinicaltrials.gov/study/NCT04230148","title":"A Phase IV, Multi-center, Open-label Study to Determine the Safety, Tolerability and Clinical Outcomes Following Oral Administration of EGATEN™ (Triclabendazole) in Patients (6 Years of Age or Older) With Fascioliasis.","has_exemption":false,"start_date":"2022-02-11","completion_date":"2026-03-27","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04895306","publication_url":"https://clinicaltrials.gov/study/NCT04895306","title":"Exploring the Role of Testosterone as a Novel Anti-Nociceptive Agent in Women With Chronic Pain and Opioid Use","has_exemption":false,"start_date":"2022-11-15","completion_date":"2026-03-27","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06299111","publication_url":"https://clinicaltrials.gov/study/NCT06299111","title":"A Master Protocol for a Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of REGN9933 and REGN7508, Monoclonal Antibodies Against Factor XI for Prevention of Venous Thromboembolism in Patients With a Peripherally Inserted Central Catheter (ROXI-CATH)","has_exemption":false,"start_date":"2024-09-20","completion_date":"2026-03-27","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06768671","publication_url":"https://clinicaltrials.gov/study/NCT06768671","title":"An Open-label, Single-arm Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents Aged ≥12 to ≤17 Years at the Time of Study Inclusion With Active Moderate to Severe Hidradenitis Suppurativa","has_exemption":false,"start_date":"2024-12-30","completion_date":"2026-03-27","has_results":false,"results_due":false,"sponsor_name":"MoonLake Immunotherapeutics AG","sponsor_slug":"moonlake-immunotherapeutics-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05776953","publication_url":"https://clinicaltrials.gov/study/NCT05776953","title":"Evaluation of the Effects of Ketorolac 15mg IV Versus 30mg IV on Duration of Analgesia in Patients Who Present to the Emergency Department With Renal Colic","has_exemption":false,"start_date":"2023-12-21","completion_date":"2026-03-28","has_results":false,"results_due":false,"sponsor_name":"Hackensack Meridian Health","sponsor_slug":"hackensack-meridian-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07103941","publication_url":"https://clinicaltrials.gov/study/NCT07103941","title":"Effectiveness of Interocclusal Aligner (IOA) on Preventing Occlusal Changes in Patients Treated With a Mandibular Advancement Device (MAD): A Preliminary Study","has_exemption":false,"start_date":"2025-11-17","completion_date":"2026-03-28","has_results":false,"results_due":false,"sponsor_name":"Isabel Moreno Hay","sponsor_slug":"isabel-moreno-hay","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04895696","publication_url":"https://clinicaltrials.gov/study/NCT04895696","title":"A Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Afimetoran in Participants With Active Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2021-10-11","completion_date":"2026-03-29","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05392946","publication_url":"https://clinicaltrials.gov/study/NCT05392946","title":"Phase 1/2 Trial of Iberdomide in Combination With Daratumumab, BortEzomib and DexamethAsone in Patients With Newly Diagnosed Multiple MyeLoma (IDEAL)","has_exemption":false,"start_date":"2022-08-11","completion_date":"2026-03-29","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02703207","publication_url":"https://clinicaltrials.gov/study/NCT02703207","title":"Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD","has_exemption":false,"start_date":"2016-08-17","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02704858","publication_url":"https://clinicaltrials.gov/study/NCT02704858","title":"An Open-Label, Phase 1/2A Dose Escalation Study of Safety and Efficacy of NEO100 in Recurrent or Progressive Grade III or Grade IV Gliomas With IDH1 Mutation","has_exemption":false,"start_date":"2017-08-01","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Neonc Technologies, Inc.","sponsor_slug":"neonc-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03175224","publication_url":"https://clinicaltrials.gov/study/NCT03175224","title":"Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects With Non-Small Cell Lung Cancer With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors","has_exemption":false,"start_date":"2017-09-27","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Apollomics Inc.","sponsor_slug":"apollomics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03609580","publication_url":"https://clinicaltrials.gov/study/NCT03609580","title":"Post-operative Urinary Retention (POUR) Following Thoracic Surgery","has_exemption":false,"start_date":"2018-05-07","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Hackensack Meridian Health","sponsor_slug":"hackensack-meridian-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04420884","publication_url":"https://clinicaltrials.gov/study/NCT04420884","title":"An Open-label, Dose Escalation, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-676 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2020-07-22","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04093219","publication_url":"https://clinicaltrials.gov/study/NCT04093219","title":"PANDORA: Scheduled Prophylactic 6-hourly Intravenous Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients","has_exemption":false,"start_date":"2020-08-11","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04458545","publication_url":"https://clinicaltrials.gov/study/NCT04458545","title":"Phase 1A/1B Clinical Trials of Multivalent Opioid Vaccine Components","has_exemption":false,"start_date":"2020-10-08","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03668041","publication_url":"https://clinicaltrials.gov/study/NCT03668041","title":"CSP #2016 - National Adaptive Trial for PTSD Related Insomnia","has_exemption":false,"start_date":"2021-02-25","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04620239","publication_url":"https://clinicaltrials.gov/study/NCT04620239","title":"Multicenter Phase 3 Pivotal Study to Evaluate the Safety and Efficacy of TOOKAD (Padeliporfin) Vascular Targeted Photodynamic Therapy in the Treatment of Low Grade Upper Tract Urothelial Cancer","has_exemption":false,"start_date":"2021-03-22","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Steba Biotech S.A.","sponsor_slug":"steba-biotech-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04697004","publication_url":"https://clinicaltrials.gov/study/NCT04697004","title":"A Randomized, Multi-Center, Prospective, Safety and Efficacy Study Comparing the Outcome of Total Reverse Shoulder Arthroplasty (RSA) with SMR Stemless Reverse Vs SMR Reverse Shoulder System","has_exemption":false,"start_date":"2021-04-01","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Limacorporate S.p.a","sponsor_slug":"limacorporate-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04779918","publication_url":"https://clinicaltrials.gov/study/NCT04779918","title":"A Prospective Study Evaluating the Clinical Outcomes of Ventral or Inguinal Hernias Treated Robotically With OviTex® Reinforced Tissue Matrix","has_exemption":false,"start_date":"2021-04-29","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Tela Bio Inc","sponsor_slug":"tela-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04214535","publication_url":"https://clinicaltrials.gov/study/NCT04214535","title":"Anterior Cervical Disectomy And Fusion Using The Tritanium® C Anterior Cervical Cage For One Or Two-Levels: A Clinical And Radiographic Analysis Pilot Study","has_exemption":false,"start_date":"2021-05-05","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Corewell Health East","sponsor_slug":"corewell-health-east","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04896697","publication_url":"https://clinicaltrials.gov/study/NCT04896697","title":"A First-in-Human, Multicenter, Phase 1/2, Open-Label Study of Vilastobart (XTX101) Monotherapy and Vilastobart (XTX101) and Atezolizumab Combination Therapy in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2021-09-13","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Xilio Development, Inc.","sponsor_slug":"xilio-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05268289","publication_url":"https://clinicaltrials.gov/study/NCT05268289","title":"An Adaptive, Randomized, Double-blind, Dose Exploration, Parallel Group, Placebo Controlled, Multicenter Phase 2 Trial to Evaluate the Efficacy, Safety and Tolerability of LNP023 in Combination With Standard-of-care With and Without Oral Corticosteroids in Patients With Active Lupus Nephritis Class III-IV, +/- V","has_exemption":false,"start_date":"2022-08-10","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05230810","publication_url":"https://clinicaltrials.gov/study/NCT05230810","title":"This is a Multicenter, Single Arm, Open-label, run-in Phase Ib / Roll-over Phase II Study of Tucatinib in Combination With Alpelisib in Subjects With PIK3CA-mutant HER2-positive Locally Advanced Unresectable or Metastatic Breast Cancer.","has_exemption":false,"start_date":"2022-08-25","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Criterium, Inc.","sponsor_slug":"criterium-inc","status":"ongoing","is_pact":false,"days_late":null}]}